Blaze Vector Production

We provide Blaze Vector Production to help researchers and gene therapy developers access turnkey, scalable, research-grade vector production at 1-40L without a long-term commitment.

begin with blaze

Starting with the End in Mind

Blaze leverages Forge’s proprietary, commercially viable technologies, including our HEK293 suspension Ignition Cells™, pEMBR™ 2.0 Ad helper plasmid, and modified rep/cap plasmids to enable efficient and scalable AAV production, from research through cGMP manufacturing. Developers use Blaze for:

  • Generating research-grade AAV material
  • Identifying lead therapeutic candidate
  • Understanding the manufacturability of your vector
  • Seamless scale up to cGMP

Process

How Blaze Works

Promising early data often signals the need to scale AAV production beyond what in-house capabilities can support. Blaze bridges this gap by producing research-grade AAV for proof-of-concept studies and evaluating vector manufacturability, helping developers confidently advance early-stage discovery work.

A scientist at Forge Biologics in a laboratory.

Ready for growth

Post-Research Support

Forge provides the same expert guidance and support for your program as it moves toward clinical production. With your proof-of-concept in place, we continue to support your journey with integrated AAV manufacturing services tailored to your next phase.

Blaze vector production. Forge your way.

Power Your Discovery with Blaze

Connect with our client development team to get started with Blaze.

Hot of the Forge